Peterson & Co. acts for Revive Therapeutics Ltd. in Rights Offering

On May 16, 2016, Revive Therapeutics Ltd. (TSXV:  RVV) announced a best efforts rights offering to raise $2.2 million.  Revive is focused on commercializing treatments for gout, and rare diseases such as cystinuria, Wilson’s disease and Rett syndrome.


Recent Transactions

31 December 2021

Peterson McVicar Acts for Bitfarms in $100 Million Credit Facility

Learn More

08 December 2021

Peterson McVicar Acts for Red Cloud in Upsize of Fission 3.0 Brokered Private Placement to up to C$7.5 Million

Learn More

11 November 2021

Peterson McVicar acts for Bitfarms as it Acquires 24 Megawatts of Hydro Power in the U.S. and Enters into Memorandum of Understanding to Expand Up to 99 MW

Learn More

09 November 2021

Peterson McVicar Acts for HIVE Blockchain in $110,020,000 Bought Deal Private Placement Financing

Learn More